IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Argos Therapeutics Inc

CUSIP: 040221103 | 97 institutional holders

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

Pharmstandard International S.A.826,153
0.3% of portfolio›$83
StyleTurnoverLocationFiled
Pharmstandard International S.A.
826,153$830.3%N/AN/ALuxembourg, Netherlands2018-11-15